SIMPONI ARIA ® (golimumab) Approved by the U.S. Food and Drug Administration for Active Polyarticular Juvenile Idiopathic Arthritis and Extension of Its Active Psoriatic Arthritis Indication in Patients 2 Years of Age and Older
HORSHAM, PA, September 30, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONI ARIA® (golimumab) for patients 2 years of age and older for the treatment of active pJIA and has extended the PsA indication for this same patient population. “This latest FDA approval of SIMPONI ARIA for pediatric use in active pJIA and active PsA not only brings a new option to young patients living with these diseases but also adds to the growing body of evidence for this treatment,” said Mathai Mammen, M.D., Ph.D., Glo...
Source: Johnson and Johnson - September 30, 2020 Category: Pharmaceuticals Source Type: news

Predictors of Histological Remission in Ulcerative Colitis Predictors of Histological Remission in Ulcerative Colitis
This study aimed to identify the feasibility and predictors of achieving histologic remission in patients with ulcerative colitis treated-to-target of endoscopic healing.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 30, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Drug found to correct gene defect that causes immune-driven gut leakiness
(University of California - Riverside) A team of researchers led by biomedical scientist Declan McCole at the University of California, Riverside, has found that the drug tofacitinib, also called Xeljanz and approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, can repair permeability defects in the intestine. " Our work could help improve identification of patients who will be better responders to this drug, " says McCole, a professor of biomedical sciences in the School of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 29, 2020 Category: International Medicine & Public Health Source Type: news

Study reveals dietary fructose heightens inflammatory bowel disease
(Stony Brook University) Diet remains an important part of disease prevention and management, and a new study suggests that consumption of fructose may worsen intestinal inflammation common to inflammatory bowel diseases (IBD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 29, 2020 Category: International Medicine & Public Health Source Type: news

Hyperbaric Oxygen Therapy for Flares in Ulcerative Colitis Hyperbaric Oxygen Therapy for Flares in Ulcerative Colitis
How effective is hyperbaric oxygen for improving outcomes in hospitalized ulcerative colitis patients with acute moderate-severe flares refractory to standard medical therapy?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 28, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Cell therapy designed to treat inflammatory bowel disease
(University of the Basque Country) The UPV/EHU's NanoBioCel research group has for many years been developing systems enabling cells to be used as drugs. Cell therapy raises hopes for treating those diseases for which there are as yet no effective pharmacological solutions. Biomaterials, a leading journal in the field of materials sciences and medicine, has just published the paper 'Multifunctional biomimetic hydrogel systems to boost the immunomodulatory potential of mesenchymal stromal cells'. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 28, 2020 Category: International Medicine & Public Health Source Type: news

Fertility Rates Lower in Women With Inflammatory Bowel Disease
FRIDAY, Sept. 25, 2020 -- Fertility is lower in women with inflammatory bowel disease (IBD), according to a study published online Sept. 19 in the Journal of Crohn's and Colitis. Emma Druvefors, from County Hospital Ryhov in J önköping, Sweden, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 25, 2020 Category: Pharmaceuticals Source Type: news

Berry good news -- new compound from blueberries could treat inflammatory disorders
(Tokyo University of Science) Inflammatory bowel disease (IBD), caused by chronic inflammation in the digestive tract linings, can be debilitating and life threatening. Therapeutic options include suppression of immune response, but treatments leading to complete cure of IBD are still not available. Recently, a team of researchers of Tokyo University of Science has discovered a polyphenolic compound derived from blueberry that shows remarkable immunosuppressive effects and can be useful in treating IBD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 23, 2020 Category: International Medicine & Public Health Source Type: news

What Are Systemic Disease Causes of Oral Ulcers?
Discussion Oral ulcers are common problems seen by dentists but pediatricians also see them. Usually families have are concerned because they are painful and acute. Ulcers are sometime noticed by the physician and not the family as in the case of herpangina or hand-foot and mouth disease. Chronic or recurrent ulcerations present less commonly and therefore it may be more difficult to determine their etiology. Many of the systemic disease causes of oral ulcers are overall infrequent and/or not common in the pediatric age range. Ulcers can be classified in several ways but acute ulcers are usually painful and last less tha...
Source: PediatricEducation.org - September 21, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

He Had Recurring Pain for Nearly a Decade
The muscles from his buttock down to his calf felt as if they were on fire. He saw countless specialists, but nothing really seemed to help. What could it possibly be? (Source: NYT Health)
Source: NYT Health - September 15, 2020 Category: Consumer Health News Authors: Lisa Sanders, M.D. Tags: Crohn ' s Disease Digestive Tract Immune System Arthritis Colitis Source Type: news

University of South Carolina study reveals how cannabinoids may be useful to prevent colon cancer
(University of South Carolina) Inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis are caused by inflammation of the gastrointestinal tract. Patients with IBD are at a higher risk of developing colorectal cancer. A UofSC study shows that THC suppressed inflammation in the colon, preventing the onset of cancers caused by a carcinogen. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 15, 2020 Category: Cancer & Oncology Source Type: news

Survival Mortality Ulcerative Colitis
Survival and Cause-Specific Mortality in Ulcerative Colitis (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 11, 2020 Category: General Medicine Source Type: news

Inflammatory Bowel Disease Tied to Subsequent Rhinosinusitis
THURSDAY, Sept. 10, 2020 -- Personal history of inflammatory bowel disease (IBD) is associated with an increased risk for subsequent chronic rhinosinusitis (CRS), according to a study published online Sept. 4 in Clinical Otolaryngology. Yu-Shuna... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 10, 2020 Category: Pharmaceuticals Source Type: news

Ulcerative Colitis
Title: Ulcerative ColitisCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 9/2/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - September 2, 2020 Category: Nutrition Source Type: news

What Is Ulcerative Colitis, the Ailment Afflicting Shinzo Abe of Japan?
The disease that has afflicted Prime Minister Shinzo Abe of Japan is a chronic malady that can strike at a young age and flare up unpredictably. (Source: NYT Health)
Source: NYT Health - August 28, 2020 Category: Consumer Health News Authors: Rick Gladstone Tags: Digestive Tract Colitis Bowels Crohn ' s Disease Colon Clinical Gastroenterology and Hepatology (Journal) Massachusetts General Hospital Abe, Shinzo Source Type: news

Inflammatory Bowel Disease (IBD) Diet
Title: Inflammatory Bowel Disease (IBD) DietCategory: Diseases and ConditionsCreated: 9/20/2017 12:00:00 AMLast Editorial Review: 8/27/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - August 27, 2020 Category: Nutrition Source Type: news

Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs
In an oversubscribed round, top-tier investors provide significant financial resources to accelerate clinical development of potentially best-in-class therapies for inflammatory/autoimmune diseases SAN DIEGO and TAICANG, SUZHOU, China, Aug. 24, 2020 -- ... Biopharmaceuticals, Venture Capital, Personnel Connect Biopharma, atopic dermatitis, ulcerative colitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 24, 2020 Category: Pharmaceuticals Source Type: news

Inflammatory bowel disease linked to an immune cell run amok
(University of California - San Diego) Researchers at UC San Diego School of Medicine report that the lasting nature of inflammatory bowel disease may be due to a type of long-lived immune cell that can provoke persistent, damaging inflammation in the intestinal tract. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 24, 2020 Category: International Medicine & Public Health Source Type: news

Antibiotic Exposure Linked to Risk for Inflammatory Bowel Disease
THURSDAY, Aug. 20, 2020 -- Higher cumulative exposure to antibiotics is associated with an increased risk for new-onset inflammatory bowel disease (IBD), according to a study published online Aug. 17 in The Lancet Gastroenterology&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 20, 2020 Category: Pharmaceuticals Source Type: news

Childbearing and Short-Term Risk of Crohn Disease in Mothers Childbearing and Short-Term Risk of Crohn Disease in Mothers
Does childbearing influence the risk of inflammatory bowel disease?American Journal of Epidemiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 18, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Roche provides update on phase III studies of etrolizumab in people with moderately to severely active ulcerative colitis
Basel, 10 August 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced topline results from its phase III study programme evaluating the investigational medicine etrolizumab in people with moderately to severely active ulcerative colitis. Mixed results were seen in studies evaluating etrolizumab as an induction therapy, and both studies evaluating etrolizumab as a maintenance therapy failed to meet their primary endpoints, showing no significant difference in the proportion of people achieving remission with subcutaneous etrolizumab versus placebo. In the HIBISCUS I induction study, in people without prior anti-tumour ...
Source: Roche Media News - August 10, 2020 Category: Pharmaceuticals Source Type: news

Roche provides update on phase III studies of etrolizumab in people with moderately to severely active ulcerative colitis
Basel, 10 August 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced topline results from its phase III study programme evaluating the investigational medicine etrolizumab in people with moderately to severely active ulcerative colitis. Mixed results were seen in studies evaluating etrolizumab as an induction therapy, and both studies evaluating etrolizumab as a maintenance therapy failed to meet their primary endpoints, showing no significant difference in the proportion of people achieving remission with subcutaneous etrolizumab versus placebo. In the HIBISCUS I induction study, in people without prior anti-tumour ...
Source: Roche Investor Update - August 10, 2020 Category: Pharmaceuticals Source Type: news

What Are the Five Types of Crohn's Disease?
Title: What Are the Five Types of Crohn's Disease?Category: Diseases and ConditionsCreated: 8/7/2020 12:00:00 AMLast Editorial Review: 8/7/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - August 7, 2020 Category: Nutrition Source Type: news

What Is the Life Expectancy of Someone With Ulcerative Colitis?
Title: What Is the Life Expectancy of Someone With Ulcerative Colitis?Category: Diseases and ConditionsCreated: 8/6/2020 12:00:00 AMLast Editorial Review: 8/6/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - August 6, 2020 Category: Nutrition Source Type: news

How Serious Is Ulcerative Colitis?
Title: How Serious Is Ulcerative Colitis?Category: Diseases and ConditionsCreated: 8/6/2020 12:00:00 AMLast Editorial Review: 8/6/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - August 6, 2020 Category: Nutrition Source Type: news

Biodiversity Loss Could be Making Us Sick – Here ’ s Why
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post Biodiversity Loss Could be Making Us Sick – Here’s Why appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - August 5, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Biodiversity Environment Global Headlines Health TerraViva United Nations Source Type: news

What Is the Life Expectancy of Someone with Crohn's Disease?
Title: What Is the Life Expectancy of Someone with Crohn's Disease?Category: Diseases and ConditionsCreated: 8/4/2020 12:00:00 AMLast Editorial Review: 8/4/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - August 4, 2020 Category: Nutrition Source Type: news

An interspecies translation model implicates integrin signaling in infliximab-resistant inflammatory bowel disease
Anti–tumor necrosis factor (anti-TNF) therapy resistance is a major clinical challenge in inflammatory bowel disease (IBD), due, in part, to insufficient understanding of disease-site, protein-level mechanisms. Although proteomics data from IBD mouse models exist, data and phenotype discrepancies contribute to confounding translation from preclinical animal models of disease to clinical cohorts. We developed an approach called translatable components regression (TransComp-R) to overcome interspecies and trans-omic discrepancies between mouse models and human subjects. TransComp-R combines mouse proteomic data with pa...
Source: Signal Transduction Knowledge Environment - August 4, 2020 Category: Science Authors: Brubaker, D. K., Kumar, M. P., Chiswick, E. L., Gregg, C., Starchenko, A., Vega, P. N., Southard-Smith, A. N., Simmons, A. J., Scoville, E. A., Coburn, L. A., Wilson, K. T., Lau, K. S., Lauffenburger, D. A. Tags: STKE Research Articles Source Type: news

Antibiotics use early in life increases risk of inflammatory bowel disease later in life
(Rutgers University) Even short, single antibiotic courses given to young animals can predispose them to inflammatory bowel disease (IBD) when they are older, according to Rutgers researchers. The study, published in Genome Medicine, provides further evidence supporting the idea that the use of antibiotics in children under 1 year old disrupts the intestinal microbiota - the trillions of beneficial microorganisms that live in and on our bodies - that play a crucial role in the healthy maturation of the immune system and the prevention of diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 28, 2020 Category: International Medicine & Public Health Source Type: news

COVID-19 in Patients With Inflammatory Bowel Diseases COVID-19 in Patients With Inflammatory Bowel Diseases
This study investigated the clinical characteristics and implications of COVID-19 in IBD patients.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 22, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Assessing Symptoms, Blood, Stool Markers Best for Identifying Pediatric IBD
TUESDAY, July 21, 2020 -- For pediatric patients with nonbloody diarrhea, evaluating symptoms plus blood and stool markers is the optimal test strategy for predicting inflammatory bowel disease (IBD), according to a study published online July 21 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 21, 2020 Category: Pharmaceuticals Source Type: news

Chronic inflammation alters the evolution of cells in the colon, study finds
(Wellcome Trust Sanger Institute) Researchers have compared diseased colon with healthy tissue to better understand how inflammatory bowel disease (IBD) is linked to an increased risk of colorectal cancers, at a molecular level. Researchers from the Wellcome Sanger Institute and collaborators found that the rate of DNA change within colon cells affected by IBD was more than double that in healthy colon, increasing the likelihood of these cells gaining DNA changes that could lead to cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 21, 2020 Category: Cancer & Oncology Source Type: news

High-fat diet with antibiotic use linked to gut inflammation
(University of California - Davis Health) UC Davis researchers have found that combining a Western-style high-fat diet with antibiotic use significantly increases the risk of developing pre- inflammatory bowel disease. This combination shuts down the mitochondria in cells of the colon lining, leading to gut inflammation. Mesalazine can help restart the mitochondria and treat pre-IBD condition. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 14, 2020 Category: International Medicine & Public Health Source Type: news

High-Fiber, Low-Fat Diet for Ulcerative Colitis
Title: High-Fiber, Low-Fat Diet for Ulcerative ColitisCategory: Health NewsCreated: 7/10/2020 12:00:00 AMLast Editorial Review: 7/13/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - July 13, 2020 Category: Nutrition Source Type: news

High-Fiber, Low-Fat Diet May Help People With Ulcerative Colitis
FRIDAY, July 10, 2020 -- A low-fat, high-fiber diet may improve the quality of life of patients with ulcerative colitis, a new study finds. " Patients with inflammatory bowel disease always ask us what they should eat to make their symptoms better, " ... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 10, 2020 Category: General Medicine Source Type: news

Help Shape Our Reporting on Disability and Accessibility in America
Our journalists want to hear your questions about and experiences with disability and accessibility in the U.S. (Source: NYT Health)
Source: NYT Health - July 10, 2020 Category: Consumer Health News Authors: Hannah Wise Tags: Crohn ' s Disease Americans With Disabilities Act United States Source Type: news

Inflammatory Bowel Disease and Pancreatic Cancer Inflammatory Bowel Disease and Pancreatic Cancer
Do patients with IBD have a significantly increased risk of pancreatic cancer?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 6, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Inflammatory Bowel Disease Tied to Increased Dementia Risk
Those with Crohn ’s disease or ulcerative colitis had higher rates of Alzheimer’s disease and other forms of dementia. (Source: NYT Health)
Source: NYT Health - July 2, 2020 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Alzheimer ' s Disease Dementia Digestive Tract Crohn Source Type: news

Better Data Shed More Light on Ulcerative Colitis Surgery Better Data Shed More Light on Ulcerative Colitis Surgery
An inflammatory bowel disease (IBD) surgery registry that adds IBD-specific variables to general quality measurements for restorative proctocolectomy with ileal pouch-anal anastomosis (RPC-IPAA) performed for ulcerative colitis (UC) allows a better interpretation of predictive factors for delayed pouch formation, according to a new study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 1, 2020 Category: Surgery Tags: Gastroenterology News Source Type: news

IBD Risk Among Obese Patients After Bariatric Surgery IBD Risk Among Obese Patients After Bariatric Surgery
Does surgical or medical treatment for obesity reduce the risk of developing new-onset inflammatory bowel disease?Alimentary Pharmacology & Therapeutics (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 29, 2020 Category: Surgery Tags: Gastroenterology Journal Article Source Type: news

Inflammatory Bowel Disease Tied to a Doubling of Dementia Risk Inflammatory Bowel Disease Tied to a Doubling of Dementia Risk
Increased dementia risk and earlier onset of dementia in patients with IBD support a role for the gut – brain axis and chronic inflammation in progressive neurocognitive decline.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 26, 2020 Category: Neurology Tags: Psychiatry News Source Type: news

Janssen Announces Discontinuation of Phase 3 LOTUS Study Evaluating Ustekinumab in Systemic Lupus Erythematosus
SPRING HOUSE, PENNSYLVANIA, June 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today its decision to discontinue the Phase 3 LOTUS study of STELARA® (ustekinumab) in Systemic Lupus Erythematosus (SLE) due to lack of efficacy in SLE.The decision is based on data from a pre-planned interim efficacy analysis. Interim safety findings were consistent with the known safety profile of STELARA, and no new safety signals were identified. Investigators, study participants and health authorities have been informed of the decision. The company intends to thoroughly analyze the totality of...
Source: Johnson and Johnson - June 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Inflammatory Bowel Disease Linked to Subsequent Dementia
Risk for developing Alzheimer dementia showed the greatest increase among dementia types (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - June 24, 2020 Category: Psychiatry Tags: Family Medicine, Geriatrics, Gastroenterology, Internal Medicine, Neurology, Psychiatry, Journal, Source Type: news

Scientists link bowel inflammation to higher risk of dementia
Study is latest to find high degree of correlation between gut health and mental healthPeople living with inflammatory bowel disease (IBD) have more than twice the risk of developing dementia, researchers have revealed in the latest study to link gut health to neurological diseases.A growing body of research suggests changes in the gastrointestinal tract may affect the brain through two-way communication known as the gut-brain axis.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 24, 2020 Category: Science Authors: Nicola Davis Tags: Dementia Alzheimer's Health Parkinson's disease Mental health Motor neurone disease Society Digestive disorders Source Type: news

Inflammatory Bowel Disease Linked to Subsequent Dementia
WEDNESDAY, June 24, 2020 -- Inflammatory bowel disease (IBD) is associated with an increased risk for developing dementia, according to a study published online June 23 in Gut. Bing Zhang, from Taipei Veterans General Hospital in Taiwan, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 24, 2020 Category: Pharmaceuticals Source Type: news

Long-term Response to I.V. Steroids in Acute Severe UC Long-term Response to I.V. Steroids in Acute Severe UC
This study assessed relapse-free survival in patients with acute severe ulcerative colitis who have responding favorably to treatment with intravenous steroids.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 24, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Could Crohn's, Colitis Raise Dementia Risk?
Title: Could Crohn's, Colitis Raise Dementia Risk?Category: Health NewsCreated: 6/23/2020 12:00:00 AMLast Editorial Review: 6/24/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 24, 2020 Category: Nutrition Source Type: news

People with inflammatory bowel disease might be at higher risk for dementia, study finds
If you have inflammatory bowel disease, you may be at greater risk for developing dementia, a new study suggests. (Source: CNN.com - Health)
Source: CNN.com - Health - June 24, 2020 Category: Consumer Health News Source Type: news

Dementia risk doubled in adults with inflammatory bowel disease, study finds
Adults with inflammatory bowel disease are more than twice as likely to develop dementia than those without IBD, a study published Tuesday in the journal Gut found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 24, 2020 Category: Consumer Health News Source Type: news

Ultrasound Score Promising Measure of Crohn's Disease Ultrasound Score Promising Measure of Crohn's Disease
An ultrasound activity index combining bowel-wall thickness and color Doppler appears to be a useful surrogate marker of endoscopic activity in patients with Crohn's disease, according to Norwegian researchers.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - June 23, 2020 Category: Pathology Tags: Gastroenterology News Source Type: news